2 results
Approved WMOCompleted
Evaluate the formation of adhesions after third-generation endometrial ablation, with and without the intrauterine adhesion barrier
Approved WMOCompleted
To determine the Objective Response Rate (ORR) as assessed by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 of CriPec® docetaxel monotherapy in subjects with ovarian cancer who are resistant to prior platinum-based therapy.